Literature DB >> 7692881

Molecular basis for human immunodeficiencies.

L Hammarström1, M Gillner, C I Smith.   

Abstract

Major emphasis is currently being placed on unraveling the molecular basis of various forms of primary human immunodeficiencies. It is clear from recent studies that not only can different mutations give rise to different phenotypes but the same mutation may result in quite diverse clinical pictures. A correct diagnosis at the DNA level therefore becomes increasingly important in view of the possibility of gene therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692881     DOI: 10.1016/0952-7915(93)90041-p

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  3 in total

1.  Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.

Authors:  S R Tzeng; Y C Lou; M T Pai; M L Jain; J W Cheng
Journal:  J Biomol NMR       Date:  2000-04       Impact factor: 2.835

2.  Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.

Authors:  S R Tzeng; M T Pai; F D Lung; C W Wu; P P Roller; B Lei; C J Wei; S C Tu; S H Chen; W J Soong; J W Cheng
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

3.  A putative human equivalent of the murine Xlr (X-linked, lymphocyte-regulated) protein.

Authors:  B Allenet; D Escalier; H J Garchon
Journal:  Mamm Genome       Date:  1995-09       Impact factor: 2.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.